Domino's Pizza (DPZ) has rallied about 8% in a month to $321.38, but the bounce is running into a weekly downtrend, and the balance of evidence for the next two to six weeks leans negative. The stock is overbought, sits below its 40-week average and has met sellers near $325 before. Conviction is medium. Earnings growth and a buy-rated analyst consensus are real counterweights, but the price structure has not changed.
Why it matters
The last real event was the third-quarter report on October 13, 2026. The 10-Q filing shows revenue of $1.19 billion, up 3%, net income up 9% to $152.2 million and diluted EPS up 13% to $4.60. The quality of that growth is thinner than the EPS line suggests. According to the 8-K, U.S. same-store sales rose just 0.3% and international rose 0.2%. Global retail sales growth was 3.2% excluding currency, and the system opened a net 175 stores, 26 in the U.S. and 149 abroad. Profit is growing faster than demand at existing stores.
What the market has done since is the question. The stock is up 8.05% over the past month, yet still down 22.85% for the year and 26.7% below its 52-week high of $438.42. The supplied sources contain no news after October 13, so nothing published explains the recent climb. It looks like a rebound from a low of $283.03 rather than a reaction to a new fact. The report itself appears largely absorbed.
The last five days sort out who is doing the work. DPZ gained 3.06%, while the S&P 500 (SPY) fell 2.06% and the consumer discretionary sector (XLY) rose 1.50%. The market was a headwind and the sector a tailwind, and DPZ ran 1.6 points ahead of the sector on its own. Today the shares are down 0.3% on volume far below the 20-day average, though the session is still open. A rally on that little participation is not one buyers have yet committed to.
No debate articles were supplied, so the argument shows up in the numbers instead. The constructive side has 27 analysts with a consensus of buy and a mean price target of $356.48, plus EPS growth of 13%. The cautious side points to 0.3% U.S. same-store sales and a stock below its 200-day average. It also points to the target range itself, which runs from $257 to $425. At $321.38 the shares trade 9.8% below the mean target. That discount only matters if the analysts' growth assumptions arrive, and the spread shows they do not agree on that.
What the evidence says
On the long term, the thesis is weakened rather than intact. The price is below its 40-week average, which defines the weekly trend as down, and the 200-day average at $341.79 sits above the stock. Over 200 days DPZ trails the S&P 500 by 9.7 points. The stock is 13.55% above its 52-week low and in a counter-trend recovery. It has not started a new advance.
For the next two to six weeks the balance of evidence leans negative, with medium conviction (2 of 4). Three things drive it. First, a rally inside a weekly downtrend has reached overbought, with the 14-day RSI near 71. Second, DPZ leads the S&P 500 by 4.3% over 50 days, which runs against the trend and tends to fade. Third, it lags XLY by 0.9% over 50 days, so even its own sector has done slightly better.
The strongest case against that reading is real. The stock is above its 10-week and 50-day averages, the latter at $313.45. It has outrun its sector this week, and earnings per share are growing 13%. If buyers keep absorbing supply near $325, the overbought reading can unwind through time rather than price. That is why conviction is medium and not higher. It does not tip the balance, because the 40-week average and the 200-day average both still sit overhead. The volume behind the rally is also thin.
Levels that matter
In a downtrend the structure is capped from above. $325.00, a round number, is where sellers have shown up on rallies, with $327.79 as a swing zone just above it. The trend itself would end only above $341.79, the 200-day average. That is the level where a recovery would stop being a bounce and start to look like a change of direction.
The breakout level on the downside is a daily close below $318.45. From there the first target is the 50-day average at $313.45, and the second is the swing zone at $296.21. The move would be wrong above $327.05, which is $325.00 plus a quarter of the 14-day ATR. Against that stop the first target pays only 0.6 to 1 and the second pays 2.6 to 1. The math does not reach the 3 to 1 that makes a breakout worth the risk. Only a target at or beyond the $283.77 support would lift it past that mark, which means a break that carries well below $296.21.
What would change the picture
A weekly close above $341.79, the 200-day average, would be the price signal that the downtrend is ending. The non-price fact that could produce it is U.S. same-store sales accelerating well beyond the 0.3% reported in October. That would show demand at existing stores recovering rather than profit growth coming mostly from other sources. Without it, the analyst targets above the current price have little support from the operating numbers.
What to watch
- Next earnings: the date is not in the supplied data, and the last report was October 13, 2026. The number that matters is U.S. same-store sales, last at +0.3%.
- Sector: XLY has risen 6.49% in a month, and DPZ has moved with it. A reversal in consumer discretionary stocks would likely hit DPZ before any company news does.
- Valuation: at $321.38 the stock is 9.8% below the $356.48 mean target, with targets spanning $257 to $425. A close below $318.45 or above $325.00 would show which side of that spread the market is leaning toward.